|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 15780 |
FusionGeneSummary for H2AFZ_CD59 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: H2AFZ_CD59 | Fusion gene ID: 15780 | Hgene | Tgene | Gene symbol | H2AFZ | CD59 | Gene ID | 3015 | 966 |
| Gene name | H2A histone family member Z | CD59 molecule (CD59 blood group) | |
| Synonyms | H2A.Z-1|H2A.z|H2A/z|H2AZ | 16.3A5|1F5|EJ16|EJ30|EL32|G344|HRF-20|HRF20|MAC-IP|MACIF|MEM43|MIC11|MIN1|MIN2|MIN3|MIRL|MSK21|p18-20 | |
| Cytomap | 4q23 | 11p13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | histone H2A.ZH2AZ histone | CD59 glycoprotein1F5 antigen20 kDa homologous restriction factorCD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344)CD59 molecule, complement regulatory proteinLy-6-like proteinMEM43 antigenT cell-acti | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | P0C0S5 | P13987 | |
| Ensembl transtripts involved in fusion gene | ENST00000296417, ENST00000529158, | ENST00000534312, ENST00000395850, ENST00000533403, ENST00000351554, ENST00000415002, ENST00000445143, ENST00000426650, ENST00000437761, ENST00000527577, ENST00000528700, | |
| Fusion gene scores | * DoF score | 3 X 3 X 1=9 | 7 X 11 X 3=231 |
| # samples | 4 | 17 | |
| ** MAII score | log2(4/9*10)=2.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(17/231*10)=-0.442358105278356 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: H2AFZ [Title/Abstract] AND CD59 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BC050619 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - | ||
| ChiTaRS3.1 | BM550843 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000296417 | ENST00000534312 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-3UTR | ENST00000296417 | ENST00000395850 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-3UTR | ENST00000296417 | ENST00000533403 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-3UTR | ENST00000296417 | ENST00000351554 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-3UTR | ENST00000296417 | ENST00000415002 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000296417 | ENST00000445143 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000296417 | ENST00000426650 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000296417 | ENST00000437761 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000296417 | ENST00000527577 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000296417 | ENST00000528700 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000529158 | ENST00000534312 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-3UTR | ENST00000529158 | ENST00000395850 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-3UTR | ENST00000529158 | ENST00000533403 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-3UTR | ENST00000529158 | ENST00000351554 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-3UTR | ENST00000529158 | ENST00000415002 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000529158 | ENST00000445143 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000529158 | ENST00000426650 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000529158 | ENST00000437761 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000529158 | ENST00000527577 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
| intron-intron | ENST00000529158 | ENST00000528700 | H2AFZ | chr4 | 100870031 | - | CD59 | chr11 | 33730750 | - |
Top |
FusionProtFeatures for H2AFZ_CD59 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| H2AFZ | CD59 |
| Variant histone H2A which replaces conventional H2A in asubset of nucleosomes. Nucleosomes wrap and compact DNA intochromatin, limiting DNA accessibility to the cellular machinerieswhich require DNA as a template. Histones thereby play a centralrole in transcription regulation, DNA repair, DNA replication andchromosomal stability. DNA accessibility is regulated via acomplex set of post-translational modifications of histones, alsocalled histone code, and nucleosome remodeling. May be involved inthe formation of constitutive heterochromatin. May be required forchromosome segregation during cell division.{ECO:0000269|PubMed:15878876}. | Potent inhibitor of the complement membrane attackcomplex (MAC) action. Acts by binding to the C8 and/or C9complements of the assembling MAC, thereby preventingincorporation of the multiple copies of C9 required for completeformation of the osmolytic pore. This inhibitor appears to bespecies-specific. Involved in signal transduction for T-cellactivation complexed to a protein tyrosine kinase. The soluble form from urine retains its specificcomplement binding activity, but exhibits greatly reduced abilityto inhibit MAC assembly on cell membranes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for H2AFZ_CD59 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for H2AFZ_CD59 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for H2AFZ_CD59 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for H2AFZ_CD59 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | CD59 | C2676767 | CD59 Deficiency | 1 | CTD_human;ORPHANET;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|